Patents by Inventor Mu-Hyeon Choi

Mu-Hyeon Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine comprising recombinant CLPP protein of
    Patent number: 8828409
    Abstract: A method for immunizing a human or animal against pneumococcal infections, comprising by administering a vaccine comprising a purified recombinant caseinolytic protease P (ClpP) protein of S. pneumoniae in an immunologically effective amount to the human or animal.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: September 9, 2014
    Assignees: Sungkyunkwan University, Adelaide Research & Innovation Pty Ltd.
    Inventors: Dong-Kwon Rhee, Hyeok-Young Kwon, Mu-Hyeon Choi, Abiodun David Ogunniyi, James Cleland Paton
  • VACCINE COMPRISING RECOMBINANT CLPP PROTEIN OF STREPTOCOCCUS PNEUMONIAE
    Publication number: 20110129501
    Abstract: A method for immunizing a human or animal against pneumococcal infections, comprising by administering a vaccine comprising a purified recombinant caseinolytic protease P (ClpP) protein of S. pneumoniae in an immunologically effective amount to the human or animal.
    Type: Application
    Filed: November 24, 2010
    Publication date: June 2, 2011
    Inventors: Dong-Kwon Rhee, Hyeok-Young Kwon, Mu-Hyeon Choi, Abiodun David Ogunniyi, James Cleland Paton
  • Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae
    Publication number: 20080292662
    Abstract: This invention is about vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae. In this study, it was demonstrated that the CLPP was translocated into the cell wall after heat shock. And the immunization of mice with the pneumococcal CLPP prior to challenge with virulent D39 elicited protective immunity against systemic disease to a level comparable to that obtained with the well-characterized pneumococcal protein vaccine candidates, PSPA and Ply. Thus the pneumococcal CLPP can be used as an antigen for vaccine.
    Type: Application
    Filed: December 31, 2003
    Publication date: November 27, 2008
    Applicants: SUNGKYUNKWAN UNIVERSITY, ADLAIDE RESEARCH & INNOVATION PTY LTD (ARI)
    Inventors: Dong-Kwon Rhee, Hyeok-Young Kwon, Mu-Hyeon Choi, Abiodun David Ogunniyi, James Cleland Paton